Pure Global
NCT06395324

Fiber Effectively Educates & Directs the Microbiome Study

University of California, Davis·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Microbial Colonization
Drug/Device/Intervention
High arabinose diet
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of California, Davis
Location
Davis, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 15, 2024
End date
Dec 31, 2025
Enrollment
48 participants
Primary outcome

Fecal microbiome,Fecal glycome,Fecal SCFAs,Gastrointestinal tolerance,Stool consistency and frequency,Study food acceptability,Study expansion feasibility,Baseline period evaluation

Summary

The FEEDMe Study is a single-group, open label pilot study exploring how diverse,
 commercially available foods rich in arabinose influence the gut microbiome in adults from
 diverse populations.

ICD-10 classifications
Bacterial infection of unspecified siteOther bacterial infections of unspecified siteBacterial, viral and other infectious agentsCholeraOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06395324
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06395324 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Davis and is currently Not yet recruiting. The study focuses on Microbial Colonization. Target enrollment is 48 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.